SomaLogic announces the appointment of long-time Board member as Chief Executive Officer
Former CEO Byron Hewett steps down after successfully building the foundation for SomaLogic’s future growth
Boulder CO – April 5, 2017 – SomaLogic announced today that Board of Directors member Alister W. (Al) Reynolds has agreed to become the next company Chief Executive Officer. He is replacing Byron Hewett, who elected to step down from the role following several years of successfully leading the company through its initial growth into a successful commercial entity.
The announcement was made by SomaLogic Founder and Board Chairman Larry Gold, who praised both Hewett’s leadership over the past several years, as well as the uniquely relevant experience that Reynolds now brings to the role. “As we now enter a new phase in our development we are absolutely delighted that Al, with his deep knowledge of SomaLogic and his broad experience in healthcare, is available and willing to step into top-level leadership at this critical time,” said Gold.
Reynolds, who has served on the SomaLogic Board since 2003, said that he is both excited about taking on this new role and eager to get started. “I don’t think the potential impact of SomaLogic on the quality of life of so many people around the world can be overstated,” said Reynolds. “I have been fortunate to be a contributor to the company’s progress to date, and I look forward to serving this ground-breaking company in new ways going forward.”
In addition to his Board position at SomaLogic, Reynolds currently serves on the Board of Prodigo Solutions Inc. Previously, he served in a variety of senior executive positions for Quest Diagnostics Inc. and its predecessor company Corning Inc. for over 20 years, culminating in responsibility for the nationwide operations of Quest Diagnostics. For the past 14 years Reynolds has served on the Boards and been a private investor in several successful early-phase companies, primarily in healthcare. Reynolds holds a bachelor’s degree in economics from Colgate University and an MBA in finance from Cornell University.
“I am very proud of what the SomaLogic team has accomplished these past several years,” said Hewett, “particularly the initiation and growth of an outstanding commercial program that matches the unequalled research program already here when I arrived, and the intensive strategic planning we have done to successfully build the foundation for the company’s future growth.” Hewett cites the strategic plan as the main reason for his decision: “The different kind of leadership expertise it requires to fully achieve this strategy led me to the decision that now is the right time to hand off the baton to a new CEO.”
Hewett will stay on as an advisor to SomaLogic, and will work with the Board and Reynolds through the transition and beyond. “Byron has been a valued colleague and leader in helping SomaLogic develop a needed commercial focus,” said Gold. “We are grateful to Byron not only for his contributions to date, but also for his willingness to help and support SomaLogic in the future.”
Fintan R. Steele, Ph.D.
Chief Communications Officer
SomaLogic is committed to helping people worldwide receive timely, accurate, trustworthy and actionable information that helps them manage their personal health and wellness. To realize this vision, we are creating and delivering the ”SOMAscan Platform,” a clinically useful and affordable health information system based on comprehensive and personalized protein measurement, delivered broadly through a global ecosystem of partners and users.